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Background: Ougan (Citrus reticulata cv. Suavissima) flavedo extract (OFE) exhibited potential anti-tumor effects
with unclear underlying mechanisms. This study aims to evaluate the potential anti-metastatic activities of OFE on
human ovarian cancer cells, and investigate its inhibitory effect on epithelial-to-mesenchymal transition (EMT).
Methods: Ougan fruits were harvested. Flavedo tissues were separated and made into freeze-dried powder. Then
OFE were extracted from the powder. The components of OFE were identified by the high performance liquid
chromatography system with a detection wavelength of 280 nm for flavanones and 330 nm for polymethoxylated
flavones. Cell viability was assessed by Sulforhodamine B assay. The effects on cancer cell migration and motility
were evaluated by wound-healing and transwell assays. The mechanisms of action were investigated by examining
the modulation by OFE on EMT-related signaling pathways at the concentrations of 4 μg/mL and 20 μg/mL, using
qRT-PCR and western blot analyses.
Results: Non-cytotoxic concentrations of OFE significantly suppressed the cellular migration (4 μg/mL, P = 0.005 vs.
control group; 20 μg/mL, P = 0.003 vs. control group) and motility (4 μg/mL, P < 0.001 vs. control group; 20 μg/mL,
P < 0.001 vs. control group) of SKOV3 cells, and inhibited transforming growth factor-β1 (TGF-β1)-induced E-cadherin loss
(4 μg/mL, P = 0.002 vs. control group; 20 μg/mL, P = 0.001 vs. control group) and mesenchymal marker upregulation, e.g.,
N-cadherin (4 μg/mL, P = 0.027 vs. control group; 20 μg/mL, P = 0.013 vs. control group), vimentin (4 μg/mL, P = 0.036 vs.
control group; 20 μg/mL, P = 0.015 vs. control group) and fibronectin (4 μg/mL, P < 0.001 vs. control group; 20 μg/mL,
P < 0.001 vs. control group).
Conclusions: The anti-metastatic ability of OFE inhibited EMT by interfering with the canonical TGF-β1-SMAD-Snail/Slug
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Seventy percents of ovarian cancer patients at their first
diagnosis were found to have ascites or distant metasta-
sis. Ovarian cancer has the highest fatality rate among
gynecologic malignancies [1]. Accordingly, the develop-
ment of novel therapeutic agents to prevent or suppress
ovarian cancer metastasis, has been considered as a po-
tential strategy to improve the therapeutic effect of ovar-
ian cancer patients.
The epithelial-to-mesenchymal changes in cell pheno-
type has been defined as the epithelial–mesenchymal
transition (EMT), which plays a critical role in cancer
metastasis [2, 3]. EMT converts polarized and immotile
epithelial cells to motile mesenchymal cells, accompan-
ied by loss of cell–cell adhesion, planar and apical-basal
polarity, and acquired mesenchymal features, including
motility, invasiveness and enhanced resistance to apop-
tosis [4]. Blockage of EMT might prevent metastasis at
the early stage [5]. Natural products, e.g., Procyanidin
C1, Rubus idaeus L, Silibinin, Withania somnifera root
extract, Phenolic secoiridoids, have been tested for anti-
EMT activity in experimental models [6–10].
Ougan (Citrus reticulata cv. Suavissima) has exhibited
the wide range of biological activities. For instance, extracts
from edible tissues of citrus fruit of different species were
examined for their antioxidant capacities [11, 12], glucose
consumption activities [13–15], and anti-atherosclerosis
activities [16, 17]. The anticancer activities of these extracts
were exerted through inducing p53-dependent apoptosis
[18, 19] and anti-angiogenesis [20]. Currently, no studies
have investigated the effects of Ougan flavedo extract
(OFE) on EMT.
This study aims to evaluate the potential anti-metastatic
activities of OFE on human ovarian cancer cells, and in-
vestigate its inhibitory effect on EMT.
Methods
Preparation of OFE
Ougan fruits were harvested from Ouhai District of
Wenzhou, Zhejiang province, China in 2011. The fruit
samples were botanically authenticated by Dr. Changjie
Xu from Zhejiang University. Flavedo tissues of Ougan
fruit were manually separated. They were frozen in li-
quid nitrogen and then stored at −80 °C. After freeze-
drying (FM 25EL-85, VirTis, USA), they were ground
into a fine powder and stored at −80 °C until extraction
and analysis. Lyophilized Ougan flavedo powder (1 g)
was dissolved in 20 mL of 80 % acetone (solid–liquid ra-
tio 1:20) and then sonicated (JBT/C-YCL500T/3P,
Jinbaite Electronic Co., Ltd, Jining, China) for 30 min,
with a frequency of 60 kHz and a power of 30 W
(Fig. 1a). The extract was centrifuged (Centrifuge 5804
R, Eppendorf, Germany) at 1932 × g for 10 min. The
residue was extracted twice as described above, and thesupernatants were combined and evaporated on a ro-
tary evaporator (Heidolph, LABOROTA 4000-efficient,
Germany), and the residue was dissolved in 10 mL of
deionized water. Samples were then purified by a C18
Sep-Pak Cartridge column (12 cc/2 g, Waters, Milford,
MA, USA). First, the column was activated by 20 mL of
methanol, and balanced with 20 mL of deionized water.
The aqueous solution was loaded at a rate of 1 mL/
min. After the column was fully adsorbed, it was
washed with 40 mL of deionized water to remove the
sugar, acid and other polar substances in the flavedo.
The column was eluted with 40–80 mL of methanol
(depending on the eluting color) and the eluent was
evaporated into powder; this residue was OFE and was
analyzed by the high performance liquid chromatography
(HPLC) system. OFE was used for the bioactivity assay.
Naringin, hesperidin, neohesperidin, naringenin, hespere-
tin, and acetonitrile were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Sinensetin was purchased from
Hengdailao, Co., Ltd. (Shanghai, China). Nobiletin and
tangeretin were the products of J&K Scientific Ltd.
(Shanghai, China). 5-Hydroxy-6,7,8,3’ ,4’-pentamethoxyfla-
vone (5HPMF) was purchased from Feiyu Bio tech Co.,
Ltd. (Nantong, China).HPLC analysis
Flavonoid compounds in OFE were analyzed by HPLC
according to Sun et al. [20] with some modifications. An
HPLC system (2695 pump, 2996 diode array detector,
Waters, Milford, MA, USA) coupled with an ODS C18
analytical column (Waters, Sunfire, 4.6 × 250 mm, i.d.,
5 μm, Milford, MA, USA) was used with a detection
wavelength of 280 nm for flavanones and 330 nm for
polymethoxylated flavones. The mobile phase of HPLC
consisting of deionized water (A) and acetonitrile (B)
was performed as follows: 0–15 min, 20 % B; 15–
35 min, 20–60 % B; 35–40 min, 60–100 % B; 40–
42 min, 100 % B; 42–45 min, 10–20 % B; 45–50 min,
20 % B. The separation temperature was set at 25 °C
and the flow rate was 1 mL/min.Cell culture
Human ovarian cancer cell line SKOV-3 was purchased
from Shanghai Institute of Biochemistry and Cell Biol-
ogy, Chinese Academy of Medical Sciences (TCHu185,
Shanghai, China). SKOV3 cells were maintained in
RPMI-1640 medium (Gibco, Grand Island, NY, USA)
supplemented with 10 % FBS (Gibco, Grand Island, NY,
USA) and cultured in a humidified atmosphere of 95 %
air plus 5 % CO2 at 37 °C. Cells were plated the day be-
fore to induce EMT. After starvation in serum-free
medium overnight, 5 ng/mL TGF-β1 was added; cells
were examined after treatment for 16 h.
Fig. 1 Extraction and identification of OFE. a Preparation procedure of OFE. b HPLC profile of OFE (λ = 280 nm)
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SKOV3 cell viability after OFE exposure was evaluated
by Sulforhodamine B (SRB) assay. After the incubation
period, cell monolayers were fixed with 10 % (wt/vol)
trichloroacetic acid and stained for 1 h at 4 °C. The
plates were washed five times with deionized water, and
then dried in an oven at 60 °C. When completely dry,50 μL of SRB was added to each well for 20 min, and
then the excess dye was removed by washing five times
with 1 % (vol/vol) acetic acid, followed by further drying
in an oven at 60 °C. The protein-bound dye was dis-
solved in 10 mM Tris-base solution for OD determin-
ation at 510 nm by a Multiskan Spectrum (Thermo
Electron Corporation, Marietta, OH, USA). Cell viability
Chang et al. Chinese Medicine  (2015) 10:14 Page 4 of 10was calculated for each well as [OD510 treated cells/
OD510 control cells] × 100 %.
Wound-healing assay
Cells were plated in 24-well culture plates in complete
culture medium and grown to confluence. A wound was
made by scraping the middle of the cell monolayer with
a sterilized 200-μL pipette tip. Cells were then cultured
with fresh complete culture medium containing 10 %
FBS with OFE or the vehicle (0.2 % DMSO). Then, the
ability of cells to migrate into the cleared section was
observed and photographed by a microscope (Leica DMI
4000 B, Wetzlar, Germany).
Transwell assay
A Boyden chamber system (Costar Corp., Cambridge,
MA, USA) was used for transwell migration assays. A
total of 3 × 104 SKOV3 cells (serum-starved overnight)
were seeded into each insert in serum-free media, while
serum with or without OFE treatment was placed in the
wells below. After incubation for 24 h, cells remaining in
the top of the inserts were removed using a cotton swab.
The cells that had migrated through the filter were fixed
with 75 % ethanol for 30 min followed by 0.1 % crystal
violet staining for 20 min. The ability of cells to migrate
to the lower chamber was observed and photographed
by microscopy (Leica DMI 4000 B, Wetzlar, Germany).
Then an equal volume of 10 % acetic acid was added to
each well to completely dissolve the stained crystal vio-
let. OD570 was read by a Multiskan Spectrum (Thermo
Electron Corporation, Marietta, OH, USA) to quantify
the percentage of migrated cells.
Western blot analysis
Protein samples were size-fractionated by SDS-PAGE
and transferred to PVDF membranes (Millipore, Bed-
ford, UK). Blots were blocked for 1 h in 5 % milk/0.1 %
Tween 20 in phosphate buffered saline (PBS-T) and then
incubated with primary antibodies (1: 1000) at 4 °C over-
night. Blots were then washed three times for 15 min in
PBS-T, followed by incubation with secondary antibody (ac-
cording to different primary antibodies, HRP-conjugated
goat anti-mouse, anti-rabbit, and rabbit anti-goat IgG were
used (1: 5000, Santa Cruz, Dallas, TX)) in 5 % milk/PBS-T
for 1 h, and then washed three times for 15 min in PBS-T.
The membranes were briefly incubated with ECL detection
reagent (Amersham Biosciences, Castle Hill, Australia) to
visualize the proteins and were then exposed on X-ray film.
Primary antibodies used were as follows: anti-E-cadherin
(Cat# 610405), anti-N-cadherin (Cat# 610921) and Fibro-
nectin (Cat# 610078) were purchased from BD; anti-
Vimentin (Cat# ab8069) was from Abcam Ltd. (Cambridge,
UK); anti-Slug (Cat# 9585), anti-Smad2/3 (Cat# 3102), anti-
p-Smad2 (Cat# 3108), and anti-p-Smad3 (Cat# 9520) werefrom Cell Signaling Technology (Beverly, MA); anti-
Snail (Cat# AF3639) was from R&D (Minneapolis,
MN); anti-β-Actin (Cat# Sc-1615) was from Santa Cruz
(Dallas, Texas, US).
Real-time PCR
SKOV3 cells were treated with vehicle or OFE, followed
by TGF-β1. Subsequently, total RNA was prepared using
the EasyPure RNA Kit (Cat# H30828; TransGen Biotech,
Beijing, China). Single-strand cDNA was prepared from
the purified RNA using oligo (dT) priming (Thermoscript
RT kit; Invitrogen, Carlsbad, CA, USA), followed by
SYBR-Green real-time PCR (Qiagen, Hilden, Germany).
The sequences of oligonucleotide primers were as follows:
FN1 (forward primer: 5′-TCCAAGCGGAGAGAGT-3′;
reverse primer: 5′-GTGGGTGTGACCTGAG-3′), SNAI2
(forward primer: 5′-AGATGCATATTCGGACCCAC-3′;
reverse primer: 5′-CCTCATGTTTGTGCAGGAGA-3′),
SNAI1 (forward primer: 5′-GAAAGGCCTTCAACTGCA
AA-3′; reverse primer: 5′-TGACATCTGAGTGGGTCT
GG-3′), GAPDH (forward primer: 5′-GTCATCCATGAC
AACTTTGG-3′; reverse primer: 5’-GAGCTTGACAAA
GTGGTCGT-3’) and were synthesized by Sangon
(Shanghai, China). Reactions of 20-μL volume/well con-
tained 10-μL SYBR Premix Ex Taq (2×) (TaKaRa Biomed-
ical Technology, Otsu, Japan), 0.6-μL forward primer
(10 μM), 0.6-μL reverse primer (10 μM), 7.8-μL dH2O and
1.0-μL DNA template. RT-PCR reactions were performed
according to the manufacturer’s instructions. Reverse tran-
scription and amplification were performed at 95 °C for
15 min, followed by 40 cycles of 95 °C for 5 s and 55 °C for
30 s, and 72 °C for 30 s using an Eppendorf Mastercycler
ep Realplex 4 (Eppendorf, Hamburg, Germany), operated
by the realplex software (Eppendorf). Data quantitation
was performed by the relative standard curve method.
Statistical analysis
Experiments were performed at least three times or as in-
dicated. Data are presented as mean ± SD from three inde-
pendent experiments. Statistical analyses were performed
using ANOVA followed by LSD for comparing multiple
groups, and two-tailed Student’s t-test was employed for
two-group comparisons for Fig. 2a. P values less than 0.05
were considered significant (* P < 0.05, ** P < 0.01 and ***
P < 0.001). The concentration-dependent manner was visu-
ally determined.
Results
Identification of main compounds
Characterization of flavonoid profiles in OFE was accom-
plished by HPLC. Three flavanone glycosides, naringin,
hesperidin and neohesperidin, and four polymethoxylated
flavones, sinensetin, nobiletin, tangeretin and 5HPMF, were
Fig. 2 OFE suppressed the motility of cancer cells. a SRB assay was performed to assess the viability of SKOV3 cells in the presence of OFE. **
P < 0.01 vs. control; two-tailed Student’s t-tests. b Wound-healing assays were used to determine the effects of OFE or the DMSO vehicle on
cancer cell motility. c The wound healing results were scored in a double-blind method analyzing several areas of the wound. d Transwell assays
were also used to determine the effects of OFE or the DMSO vehicle on cancer cell motility. e Crystal violet was solubilized with 200-μL 10 % acetic
acid per well, and the migratory rate was quantified by measuring the OD. Data are presented as mean ± SD from three independent experiments. **
P < 0.01 vs. control; ANOVA followed by LSD
Chang et al. Chinese Medicine  (2015) 10:14 Page 5 of 10
Chang et al. Chinese Medicine  (2015) 10:14 Page 6 of 10identified according to retention time and UV pattern
compared with their standards (Fig. 1b).
Viability of SKOV3 cells in the presence of OFE
SRB assays were performed to assess the potential effects
of OFE on the proliferation of cancer cells. No signifi-
cant loss of SKOV3 cell viability was observed in the
presence of OFE up to 20 μg/mL for 24 h (Fig. 2a).
When the concentration of OFE reached 100 μg/mL, cell
viability was decreased to approximately 55 % (P = 0.003
vs. control group). To exclude the interference of cyto-
toxicity on cancer cell motility caused by OFE, we inves-
tigated the activities of OFE on EMT and cancer cell
motility at concentrations of 4 and 20 μg/mL.
OFE suppressed the motility of SKOV3 cells
Wound-healing and transwell assays were further uti-
lized to determine the cellular migration abilities of
SKOV3 cells after treatment with vehicle or OFE.
For wound-healing assays, medium containing 10 %
FBS with or without OFE was added after scraping to
produce a “wound”. FBS promoted SKOV3 cells to mi-
grate and close the wound, while co-incubation with
OFE significantly (4 μg/mL, P < 0.001 vs. control group;
20 μg/mL, P < 0.001 vs. control group) reversed the mi-
gration of SKOV3 cells (Fig. 2b). The results were quan-
tified using a double-blind method by analyzing several
areas of the wound (Fig. 2c).
For transwell assays, SKOV3 cells were treated with or
without OFE for 24 h; cells that had migrated onto the
lower surface of the porous membrane were observed
with an inverted microscope after crystal violet staining.
The total number of cells on the lower surface was in-
creased much more highly by medium containing 10 %
FBS, compared with the group without FBS stimuli
(Fig. 2d). OFE treatment (4 and 20 μg/mL) for 24 h signifi-
cantly suppressed the migration of SKOV3 cells induced
by FBS stimuli, as indicated by inhibition ratios of 57.6 %
(P = 0.005 vs. control group) and 78.2 % (P = 0.003 vs. con-
trol group), respectively (Fig. 2e).
OFE prevented TGF-β1-induced downregulation of E-
cadherin protein
TGF-β1 could induce EMT [21, 22]. We introduced TGF-
β1 to stimulate the onset of EMT, and evaluated the ef-
fects of OFE on EMT.
Loss of E-cadherin has been suggested as the main
marker of EMT occurrence [23]. Herein, we carried out
western blot analysis to estimate the protein level
changes in SKOV3 cells (Fig. 3a). E-cadherin protein
was maintained at a high level in unstimulated SKOV3
cells, but was reduced by approximately 50 % upon
TGF-β1 treatment, indicating the transition from an epi-
thelial to a mesenchymal status of TGF-β1-treated cells.However, co-incubation with OFE significantly prohib-
ited the loss of E-cadherin. As the results of semi-
quantitative densitometric analyses of western blotting
showed, E-cadherin protein levels were increased by ap-
proximately 2.5-fold after OFE treatment (Fig. 3b) (4 μg/
mL, P = 0.002 vs. control group; 20 μg/mL, P = 0.001 vs.
control group). The level of E-cadherin also increased in
unstimulated cells, suggesting that OFE could up-
regulate basal E-cadherin levels (Fig. 3a).
Collectively, these data indicated that OFE could in-
hibit TGF-β1-induced downregulation of E-cadherin in
SKOV3 cells.
OFE attenuated TGF-β1-induced augmentation of
mesenchymal markers
Increased expression of mesenchymal markers, e.g., N-
cadherin, vimentin and fibronectin, contributes to the en-
hanced motility of cancer cells. In this study, the inhibitory
effect of OFE on EMT was supported by observations of
the expression of several mesenchymal markers. In SKOV3
cells, OFE suppressed the upregulation of N-cadherin
(4 μg/mL, P = 0.027 vs. control group; 20 μg/mL, P = 0.013
vs. control group), vimentin (4 μg/mL, P = 0.036 vs. control
group; 20 μg/mL, P = 0.015 vs. control group) and fi-
bronectin (4 μg/mL, P < 0.001 vs. control group; 20 μg/
mL, P < 0.001 vs. control group) triggered by TGF-β1
(Fig. 3c), which could also be observed from semi-
quantitative densitometric analyses of western blot re-
sults (Fig. 3d, e and f ).
To investigate whether OFE transcriptionally regulated
the expression of mesenchymal markers, we used quan-
titative real-time PCR to examine the mRNA levels of fi-
bronectin (FN1). Upon TGF-β1 stimulation, FN1 mRNA
levels increased remarkably, while in the OFE-treated
groups, the increase caused by TGF-β1 was attenuated
(Fig. 4a) (4 μg/mL, P = 0.009 vs. control group; 20 μg/
mL, P = 0.008 vs. control group).
TGF-β1-induced upregulation of Slug protein and mRNA
expression was blocked by OFE
The individual extracellular inducers provoke the expres-
sion of EMT-associated transcription factors [24], such as
Twist, Snail, Slug or ZEB1, and subsequent activation of
the EMT program. The importance of these transcrip-
tional factors in the activation and regulation of EMT has
been demonstrated by numerous reports [2–4, 21, 25]; of
note is the fact that we observed a remarkable decrease in
FN1 mRNA in OFE-treated cells, raising the possibility
that OFE might have a regulatory effect on transcription
factors. We investigated the effects of OFE on the expres-
sion of Slug and Snail. Distinct augmentation of Slug and
Snail protein levels could be observed in TGF-β1-treated
SKOV3 cells (Fig. 4b), which was consistent with previous
reports [26, 27]. However, such increases in Slug and Snail
Fig. 3 OFE attenuated the loss of E-cadherin and abrogated the increase in mesenchymal markers caused by TGF-β1. a SKOV3 cells treated as
indicated were assayed by western blot analysis (WB) to assess the expression of epithelial marker E-cadherin. β-actin was used as a loading control. b
The quantitative ratios are shown as relative optical densities of bands that are normalized to β-actin expression. c Mesenchymal markers, including
N-cadherin, fibronectin and vimentin, were examined by western blot analysis. (d, e and f) The quantitative ratios are shown as relative optical densities
of bands that are normalized to the expression of β-actin. Cells were incubated with TGF-β1 (5 ng/mL) and increasing concentrations of OFE
(4 and 20 μg/mL) for 48 h. * P < 0.05, ** P < 0.01 and *** P < 0.001 vs. control; ANOVA (LSD)
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upon exposure to OFE, which was further confirmed by
semi-quantitative densitometry analyses of western blot-
ting results (Fig. 4c).
qRT-PCR analysis was utilized to determine the mRNA
levels of Slug (SNAI2) and Snail (SNAI1) in SKOV3 cells.
OFE suppressed the augmentation of SNAI2 and SNAI1
mRNA under TGF-β1 stimuli, as indicated by the re-
duced fold-change from 15.3 to 9.0, and 12.6 to 5.9, re-
spectively (Fig. 4d).
These results indicated that OFE attenuated the eleva-
tion of mRNA and protein levels of Slug and Snail caused
by TGF-β1, and might result in the subsequent manipula-
tion of EMT-associated factors such as fibronectin, whosemRNA levels were reduced when TGF-β1-stimulated cells
were exposed to OFE.
Treatment of OFE interfered with TGF-β1-activated SMAD
pathway
The TGF-β1-induced SMAD signaling cascade is the ca-
nonical pathway in EMT [5]. TGF-β1 activates R-SMADs,
which form hetero-oligomers with SMAD4 regulating the
expression of some transcription factors such as Slug or
Snail [28].
To clarify the mechanism underlying the inhibitory ef-
fect of OFE on TGF-β1 signals, we explored the effect of
OFE on TGF-β1-induced phosphorylation of SMAD2
and SMAD3. In SKOV3 cells, TGF-β1 alone induced
Fig. 4 TGF-β1-induced upregulation of Slug protein and mRNA expression was blocked by OFE. a TGF-β1-induced upregulation of FN1 mRNA expression
was blocked by OFE. b Western blot analysis was performed to examine the expression of Slug and Snail after SKOV3 treatment, as indicated. c Protein
levels were further confirmed by semi-quantitative densitometry analyses. d Real-time PCR analysis to measure the mRNA levels of SNAI1 and
SNAI2 in SKOV3 cells. Data are presented as mean ± SD from three independent experiments. * P < 0.05, ** P < 0.01 and *** P < 0.001 vs.
control; ANOVA (LSD)
Fig. 5 OFE treatment counteracted TGF-β1-activated SMAD pathways. a The effect of OFE on TGF-β1-induced phosphorylation of SMAD2
and SMAD3 was investigated by western blot analysis in SKOV3 cells. b TGF-β1-induced SMAD pathway activation that resulted in EMT was
inhibited by OFE
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tivation of these two R-SMADs; co-treatment with OFE
reduced the levels of p-SMAD2 (4 μg/mL, P = 0.002 vs.
control group; 20 μg/mL, P = 0.001 vs. control group) and
p-SMAD3 (4 μg/mL, P = 0.035 vs. control group; 20 μg/
mL, P = 0.004 vs. control group), whereas the total expres-
sion of SMAD2/3 remained unchanged (Fig. 5a). OFE
modulated critical regulatory steps of the SMAD pathway
activated by TGF-β1 in EMT, in particular by abrogating
the phosphorylation of R-SMADs, and consequently
counteracting the instigation of transcriptional activity of
SMAD complexes (Fig. 5b).
Discussion
Citrus (Citrus reticulate Blanco) peel extract could induce
apoptosis in prostate tumors in a human prostate tumor
xenograft mouse model, which was accompanied by mech-
anistic downregulation of inflammatory enzymes, including
inducible nitric oxide synthase (NOS) and cyclooxygenase-
2 (COX-2), factors involved in metastasis (MMP-2 and
MMP-9), angiogenesis (vascular endothelial growth factor,
VEGF), and proliferative molecules (PCNA) [29]. The cit-
rus fruit extract from Citrus hassaku Hort. ex Tanaka sup-
pressed metastasis, probably through inhibition of C-X-C
chemokine receptor type 4 (CXCR4) and MMP-9 in
MDA-MB-231 cells [30]. However, the extract from Citrus
unshiu Marc could inhibit MDA-MB-231 cell adhesion to
endothelial cells by selective inhibition of VCAM-1, but
not MMP-9 expression [31].
In this study, OFE prevented the onset of metastasis.
OFE contained several classes of flavonoid compounds
chemically characterized as naringin, hesperidin, neohe-
speridin, poncirin, sinensetin, nobiletin, tangeretin, and 5-
hydroxy-6,7,8,3′,4′pentamethoxyflavone (5HPMF) from
HPLC analysis. Some of these bioactive chemical constitu-
ents exhibited anti-metastasis activities [32–34]. In human
breast cancer cells, nobiletin downregulated the constitutive
expression of CXCR4 and MMP-9 [32]. In human hepato-
cellular carcinoma cells, hesperidin inhibited acetaldehyde-
induced matrix metalloproteinase-9 gene expression [33].
In addition, tangeretin inhibited the invasion of MO4 cells
(Kirsten murine sarcoma virus transformed fetal mouse
cells) into embryonic chick heart fragments in vitro [34].
Little is known about the effects of these flavonoid com-
pounds on EMT. In this study we demonstrated for the
first time the inhibitory effects of OFE on ovarian cancer
metastasis, particularly interference with EMT. We
showed that OFE could inhibit TGF-β1-induced EMT
through the canonical TGF-β1-SMAD-Snail/Slug axis.
Many growth and differentiation factors, including
growth factors [35, 36], Wnt [37] and Notch proteins [38],
can induce EMT. TGF-β was first demonstrated to induce
EMT in cell culture. In this study, we observed that OFE
could interrupt the occurrence of EMT in TGF-β1-treatedSKOV3 cells through counteracting E-cadherin loss and
fibronectin upregulation. Various studies have explored
the roles of TGF-β-activated SMADs in EMT [39–41].
TGF-β binds to its receptors, leading to the activation of
SMAD2 and SMAD3 through phosphorylation by TGF-β
receptor I. Phosphorylated SMAD2 and SMAD3 form tri-
mers with SMAD4, then translocate to the nucleus where
they associate and cooperate with DNA binding transcrip-
tional factors to regulate the expression of TGF-β target
genes including SNAI1 and SNAI2 to promote EMT [42].
TGF-β receptors, SMAD2, SMAD3 and SMAD4, are all
essential for TGF-β-induced EMT, as suppressing the ex-
pression of these genes by dominant-negative forms
blocks TGF-β-induced EMT [43]. The interruption of
EMT by OFE was attributed to the intervention of the
SMAD signaling pathway, demonstrated by the attenuated
phosphorylation of SMAD2/3 and reduction in the tran-
scriptional activity of the SMAD complexes.
The suppressive effects on cell motility and EMT in
SKOV3 cells by OFE suggested the actions of this ex-
tract on ovarian cancer metastasis. Most of these effects
could be attributed to the presence of several flavonoid
compounds in the extract. But it is still unclear whether
the anti-EMT effects of the extract were due to individ-
ual or combined effects of these components. Further
studies to characterize the bioactive chemical constitu-
ents and elucidate the mechanism of action of OFE are
in progress.Conclusions
The anti-metastatic ability of OFE inhibited EMT by inter-
fering with the canonical TGF-β1-SMAD-Snail/Slug axis.
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